Basem Al-Shayeb co-founded Amber Bio and develops gene editing technologies that rewrite large sections of RNA. His research in the Doudna and Banfield labs connected microbial discovery with compact CRISPR tools.

Unclaimed profile

Basem Al-Shayeb co-founded Amber Bio and develops gene editing technologies that rewrite large sections of RNA. His research in the Doudna and Banfield labs connected microbial discovery with compact CRISPR tools.

Career

Founder at Stealth Startup from 2025 to Present
Co-Founder at Amber Bio from 2022-06 to Present
Ph.D. Candidate & NSF Research Fellow at University of California, Berkeley from 2017-08 to 2022-06
Research Associate, Space Life Sciences at NASA Ames Research Center from 2015 to 2016
BTI Research Fellow, iGEM Team Lead at BioTechnology Institute from 2014-01 to 2015-01

Cosigns Received

Vineeta AgarwalaGeneral Partner at Andreessen Horowitz
First Cosign
Jacob and Basem … have built a fast-moving, intensely creative, and yet product-focused team at Amber Bio
Source
biorxiv.org

Programmable multi-kilobase RNA editing using CRISPR-mediated trans-splicing

Co-authored research introducing programmable replacement of large RNA segments using CRISPR targeting and cellular splicing machinery.

Open ↗
Media appearance

Meet an IGI Scientist: Basem Al-Shayeb

A conversation about microbial discovery, synthetic biology, and the path from undergraduate research to genome engineering.

innovativegenomics.org · Open ↗

Basem's Collections

Basem's Lists

In these lists

Cosigns Given